August 9, 2017 4:48pm

 

Financial results also known as (AKA) earnings is a ‘scorecard’ of public stem, cell, gene and regenerative therapy's companies.

 

The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot!

By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity and whether or not it deserves their investment.


COMPANY SYMBOL NET INCOME Q2/17 LOSS Q2/17 LPS Q2/17 CASH 
Aduro Biotech, Inc. ADRO   -$19.4 M -$0.27 $377.2 M
Applied Genetic Technologies AGTC        
Asterias Biotherapeutics AST   -$8.7 M -$0.18 $11.9 M
Athersys, Inc. ATHX   -$6.3 M -$0.06 $28.6 M
Adverum Biotechnologies, Inc. ADVM   -$11.4 M -$0.27 $197.4 M
AxoGen, Inc. AXGN   -$2.1 M -$0.06 $23.9 M
Bellicum Pharmaceuticals, Inc. BLCM   -$24,5 M -$0.74 $139 M
BioLife Solutions, Inc. BLFS   -$768 K -$0.06 $2.3 M
Biostage, Inc. BSTG   -$3.6 M -$0.10

$3.42 M

Another Q of accrued liabilities

BioTime, Inc. BTX   -$11.75 M -$0.11 $20.9 M
bluebird bio BLUE   -$70.9 M -$1.73 $1.2 B
Brainstorm Cell Therapeutics Inc. BCLI   -$1 M -$0.06 $6.7 M
Caladrius Biosciences. CLBS   -$2 M -$0.22 $59.3 M
Capricor CAPR   -$3.5 M -$0.16 $12.3 M
Cellectis CLLS   6.3 M -£0.18 £237.6 M
Cesca Therapeutics, Inc KOOL        
Cytori Therapeutics, Inc. CYTX   -$6 M -$0.19 $9 M
Fate Therapeutics, Inc. FATE   -$9.6 M -$0.23 $71 M
Fibrocell Science, Inc. FCSC   -$14 M -$0.97 $15.9 M
Histogenics Corporation HSGX   -$6.5 M -$9,25 $18.5 M
ImmunoCellular Therapeutics, Ltd. IMUC   -$3.6 M -$1.02 $1.8 M
International Stem Cell ISCO   -$568 K -$0.14 $297 K
Intrexon Corporation XON   -$18.7 M -$0.16 -$157.2 M
Juno Therapeutics, Inc. JUNO   -$100.74 M -$0.74 $801.8 M
Kite Pharma, Inc. KITE   -$109.8 M -$1.945 $781.1 M
Mesoblast Limited MBLTY        
MiMedx Group, Inc MDXG +$8.1 M or +$0.07     $47.5 M
Neuralstem, Inc.  CUR   -$4.6 M -$0.39

$11.4 M

​Raised $6 M -8/1

Northwest Biotherapeutics, Inc. NWBO        
Opexa Therapeutic, Inc. OPXA   -$678.1 K -$0.09 $1.824 M
Organovo Holdings, Inc. ONVO   -$10.1 M -$0.10 $55 M
Osiris Therapeutics, Inc. OSIR        
Pluristem Therapeutics, Inc. PSTI        
ReNeuron Group PLC RENE.L        
Regenxbio RGNX   -$14.5 M -$0.47 $208.5 M
Sangamo Biosciences, Inc. SGMO   -$12.5 M -$0.17 $266.5 M
Spark Therapeutics, Inc. ONCE   -$74.4 M -$2.40

$238.6 M

new raise $350 M

Stemline Therapeutics, Inc. STML   -$15.5 M -$0.66 $93.2 M
uniQure N.V. QURE   -$21.3 M -$0.83 $104.1 M
Verastem, Inc. VSTM   -$13,4 M -$0.36 $57.9 M
Vericel Corporation VCEL   -$2.4 M -$0.07 $14 M
VistaGen Therapeutics, Inc. VTGN